Lv5
988 积分 2024-06-08 加入
Phase 2 study of anlotinib combined with taxanes and lobaplatin in the neoadjuvant treatment of triple-negative breast cancer: Efficacy, safety and biomarker analysis
22天前
已关闭
Tumor mutation burden and PIK3CA mutations are associated with pathological complete response in human epidermal growth factor receptor 2-positive breast cancer patients receiving pyrotinib combined with trastuzumab neoadjuvant treatment
22天前
已关闭
Sensitive Activatable Nanoprobes for Real-Time Ratiometric Magnetic Resonance Imaging of Reactive Oxygen Species and Ameliorating Inflammation In Vivo
22天前
已完结
Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surge
22天前
已完结
TROP2-guided aggregation-induced emission-luminogen nanoparticles overcome sacituzumab govitecan resistance via mitochondrial oxidative stress and immunogenic cell deat
22天前
已完结
Tumor PD-L1 induces β2m ubiquitylation and degradation for cancer cell immune evasion
22天前
已完结
Fig-derived exosome-like nanoparticles attenuating bone metastasis of breast cancer through establishing an anti-tumor microenvironment
22天前
已完结
Synergistic combination of the adrenergic antagonist SR59230A with common chemotherapeutic drugs and target therapies in cancer and endothelial cells
23天前
已完结
Insulin-like growth factor I regulates the expression of isoforms of Wilms' tumor 1 gene in breast cancer
1个月前
已完结
A tumor suppressor and oncogene: the WT1 story
1个月前
已完结
皖公网安备34019202002308
